...
首页> 外文期刊>Journal of Clinical Microbiology >Variations in Western blot banding patterns of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus.
【24h】

Variations in Western blot banding patterns of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus.

机译:人类T细胞淋巴病毒III型/淋巴结病相关病毒的蛋白质印迹条带模式变化。

获取原文
           

摘要

Serum samples from 27 patients infected with human T-cell lymphotropic virus type III (14 with acquired immune deficiency syndrome [AIDS] and 13 with AIDS-related complex) were examined for antibodies to viral proteins by the Western blot method and with four different commercial solid-phase enzyme-linked immunosorbent assays (ELISAs). Virus-specific bands on blots at molecular masses of 64, 55, 53, 41, 31, 24, and 17 kilodaltons were observed. Rank correlation matrices were calculated to relate the intensity of viral bands, stage of illness, and ELISA kit optical densities (ODs). Groups of bands tended to covary in intensity: p17, p24, and p55 (gag gene products); p53 and p64 (pol gene products); and p31 (pol/endonuclease gene product) and p41 (env gene product). Blots of sera from AIDS-related complex patients usually showed strong activity against all viral proteins, while those of sera from AIDS patients characteristically showed strong reactivity only at the pol/endonuclease and env bands. For one ELISA kit (Abbott Laboratories, North Chicago, Ill.), ODs correlated well with the env and pol band intensity scores, while ELISA ODs with other kits (from Litton Industries, Sunnyvale, Calif.; Electro-Nucleonics, Inc., Fairfield, N.J.; and E.I. du Pont de Nemours & Co., Inc., Wilmington, Del.) correlated closely with gag band intensity scores. We conclude that human T-cell lymphotropic virus type III Western blot patterns are determined by (i) viral protein processing pathways and (ii) the stage of illness of the patient and may reflect (iii) the ELISA method used for serum screening.
机译:通过蛋白质印迹法和四种不同的市售方法,检测了27例感染人类T细胞淋巴病毒III型(14例获得性免疫缺陷综合症[AIDS]和13例AIDS相关复合物)的患者的血清样品中的病毒蛋白抗体固相酶联免疫吸附测定(ELISA)。在印迹上观察到病毒特异性条带,分子量为64、55、53、41、31、24和17千道尔顿。计算等级相关矩阵以关联病毒条带强度,疾病阶段和ELISA试剂盒光密度(OD)。各个频段的强度趋于变化:p17,p24和p55(gag基因产物); p53和p64(pol基因产物); p31(pol /核酸内切酶基因产物)和p41(env基因产物)。与艾滋病相关的复杂患者的血清印迹通常显示出对所有病毒蛋白的强活性,而来自艾滋病患者的血清的印迹通常仅在pol /核酸内切酶和env条带上显示强反应性。对于一种ELISA试剂盒(伊利诺伊州北芝加哥的Abbott实验室),OD值与env和pol谱带强度得分具有良好的相关性,而ELISA ODs与其他试剂盒(来自加利福尼亚州桑尼维尔的Litton Industries; Electro-Nucleonics,Inc.新泽西州的费尔菲尔德;以及特拉华州威尔明顿市的EI du Pont de Nemours&Co.,Inc.)与堵嘴带强度得分密切相关。我们得出的结论是,人类T细胞淋巴病毒III型Western印迹模式由(i)病毒蛋白加工途径和(ii)患者的疾病阶段决定,并可能反映(iii)用于血清筛查的ELISA方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号